Put companies on watchlist
Inhibrx
ISIN: US45720L1070
WKN: A2PQMH
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Inhibrx · ISIN: US45720L1070 · PR Newswire (ID: 20240510NY11346)
10 May 2024 07:50PM

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWN, INBX, AVRO


NEW YORK, May 10, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Southwestern Energy Company (NYSE: SWN)'s sale to Chesapeake Energy Corporation for 0.0867 shares of Chesapeake common stock for each share of Southwestern common stock. Upon completion of the proposed transaction, Southwestern shareholders will own approximately 40% of the combined company, on a fully diluted basis. If you are a Southwestern shareholder, click here to learn more about your rights and options.

Inhibrx, Inc. (NASDAQ: INBX)'s sale to Sanofi. Under the terms of the proposed transaction, for each Inhibrx share, Inhibrx shareholders will receive $30.00 in cash, a contingent value right of $5.00, conditioned upon the achievement of a regulatory milestone, and 0.25 shares of a new publicly traded company that will retain Inhibrx's non-INBRX-101 assets. If you are a Inhibrx shareholder, click here to learn more about your rights and options.

AVROBIO, Inc. (NASDAQ: AVRO)'s merger with Tectonic Therapeutic, Inc. Upon completion of the proposed transaction, pre-merger AVROBIO shareholders are expected to own approximately 22.3% of the combined company. If you are an AVROBIO shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-swn-inbx-avro-302142412.html

SOURCE Halper Sadeh LLP

Visual performance / price development - Inhibrx
Smart analysis and research tools can be found here.
MIC: XNAS
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2025
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942